Trials / Terminated
TerminatedNCT00282763
A Research Study to Evaluate the Safety and Effectiveness of MK0686 for the Treatment of Postherpetic Neuralgia (Also Known as PHN or Post Shingles Pain) (0686-005)
Proprietary Information - Exploratory (Non-confirmatory) Trial
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Study is to test the Safety and Effectiveness of MK0686 in relieving neuropathic (chronic) pain as experienced by patients with Postherpetic Neuralgia (Also Know as PHN or Post Shingles Pain). This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time. (Full information is available to trial participants).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MK0686 |
Timeline
- Start date
- 2005-12-01
- Primary completion
- 2006-08-01
- Completion
- 2006-08-01
- First posted
- 2006-01-27
- Last updated
- 2015-11-23
Source: ClinicalTrials.gov record NCT00282763. Inclusion in this directory is not an endorsement.